Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Use of hormone replacement therapy in the prevention of osteoporosis: important new information
Hormone replacement therapy (HRT) is no longer recommended as first choice of therapy for prevention of osteoporosis.This follows a European-wide review of the balance of risks and benefits of HRT in response to growing concerns about the safety of HRT in long-term use. The following documents are available
